Valuation: QuidelOrtho Corporation

Market Cap 1.16B 1.01B 935M 867M 1.65B 110B 1.67B 11.21B 4.36B 54.3B 4.35B 4.26B 188B P/E 2026 *
-10.6x
P/E 2027 * -106x
Enterprise Value 3.53B 3.09B 2.85B 2.64B 5.01B 335B 5.09B 34.12B 13.27B 165B 13.25B 12.96B 571B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.23x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-5.56%
1 week-2.94%
Current month-2.94%
1 month+18.63%
3 months+13.48%
6 months-49.06%
Current year-40.48%
1 week 16.91
Extreme 16.91
18.77
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
06-24Free

Director

22,743 0.0335%
06-24Free

Director

20,098 0.0296%
Change 5-day change 1-year change 3-year change Capi.($)
-5.56%-2.94%-41.82%-79.77% 1.23B
+1.00%+1.13%+7.10%-24.95% 16.48B
-3.35%+9.52%+35.27%+90.40% 1.71B
-3.15%+0.52%-30.75%+32.25% 1.13B
-4.07%-2.54%-28.53%-54.68% 639M
-3.14%-7.46%-39.94%-57.41% 568M
-0.84%+2.11%+27.39%-53.31% 453M
+0.48%+2.95%-54.49%-59.17% 380M
-4.74%+0.29%-24.53%-28.11% 354M
-4.16%-7.24%+25.90%+17.47% 318M
Average -2.75%-0.89%-12.44%-21.73% 2.33B
Weighted average by Cap. -0.31%+0.30%+1.78%-18.78%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.03B 3.85B 257B 3.91B 26.22B 10.19B 127B 10.18B 9.96B 439B 2.81B 2.46B 2.26B 2.1B 3.98B 266B 4.05B 27.13B 10.55B 131B 10.53B 10.31B 454B
Net income -156M -136M -126M -116M -221M -14.79B -225M -1.51B -586M -7.3B -585M -572M -25.23B -81.93M -71.7M -66.08M -61.25M -116M -7.78B -118M -792M -308M -3.84B -308M -301M -13.26B
Net Debt 2.37B 2.07B 1.91B 1.77B 3.36B 225B 3.42B 22.91B 8.91B 111B 8.89B 8.7B 384B 2.3B 2.01B 1.85B 1.72B 3.26B 218B 3.31B 22.23B 8.64B 108B 8.63B 8.44B 372B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-07 US$17.00 -5.56% 1,179,653
26-07-06 US$18.00 -1.37% 1,059,913
26-07-02 US$18.25 +0.39% 1,222,460
26-07-01 US$18.18 +3.80% 1,536,538
26-06-30 US$17.52 -3.92% 1,688,435
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
17.00USD
Average target price
18.88USD
Spread / Average Target
+11.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock